±Û ¼öÁ¤Çϱâ
±Û¾´ÀÌ
E-mail
Homepage
±ÛÁ¦¸ñ
±Û
Until August
vicerex 350 mg
Giving regulators access to data from an existing trial,known as Elixa, to study the treatmentâ?™s cardiovascular effectscould affect the integrity of the test, the Paris-based companysaid in a statement today. The drugmaker will resubmit theapplication in 2015, after completion of the study, Sanofi said.The withdrawal isnâ?™t related to safety issues or deficiencies inthe application, Sanofi said.
ºñ¹Ð¹øÈ£
(¼öÁ¤°ú »èÁ¦½Ã ÇÊ¿ä!! )